Total synthesis of spiruchostatin A via chemoselective macrocyclization using an accessible enantiomerically pure latent thioester

Organic Letters

Volumn 11, Issue 9, 2009, Pages 1971-1974

  Calandra, Nicole A ^a   Cheng, Yim Ling ^a   Kocak, Kimberly A ^a   Miller, Justin S ^a  

^a HOBART AND WILLIAM SMITH COLLEGES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; HISTONE DEACETYLASE; SPIRUCHOSTATIN A;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; DRUG ANTAGONISM; STEREOISOMERISM; SYNTHESIS;

CYCLIZATION; HISTONE DEACETYLASES; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC; STEREOISOMERISM;

EID: 65549147694     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol900436f     Document Type: Article

References (38)

1. Masuoka, Y.; Nagai, A.; Shin-ya, K.; Furihata, K.; Nagai, K.; Suzuki, K.; Hayakawa, Y.; Seto, H. Tetrahedron Lett. 2001, 42,41.
2. Ueda, H.; Nakajima, H.; Hori, Y.; Fujita, T.; Nishimura, M.; Goto, T.; Okuhara, M. J. Antibiot. 1994, 47, 301.
3. Chen, Y.; Gambs, C.; Abe, Y.; Wentworth, P., Jr.; Janda, K. D. J. Org. Chem. 2003, 68, 8902.
4. Taori, K.; Paul, V. J.; Luesch, H. J. Am. Chem. Soc. 2008, 130, 1806.
5. Yurek-George, A.; Habens, F.; Brimmell, M.; Packham, G.; Ganesan, A. J. Am. Chem. Soc. 2004, 126, 1030.
6. Yurek-George, A.; Cecil, A. R.; Mo, A. H.; Wen, S.; Rogers, H.; Habens, F.; Maeda, S.; Yoshida, M.; Packham, G.; Ganesan, A. J. Med. Chem. 2007, 50, 5720.
7. (a) Crabb, S. J.; Howell, M.; Rogers, H.; Ishfaq, M.; Yurek-George, A.; Carey, K.; Pickering, B. M.; East, P.; Mitter, R.; Maeda, S.; Johnson, P. W.; Townsend, P.; Shin-ya, K.; Yoshida, M.; Ganesan, A.; Packham, G. Biochem. Pharmacol. 2008, 76, 463.
8. (b) Shigematsu, N.; Ueda, H.; Takase, S.; Tanaka, H.; Yamamoto, K.; Tada, T. J. Antibiot. 1994, 47, 311.
9. Ueda, H.; Manda, T.; Matsumoto, S.; Mukumoto, S.; Nishigaki, F.; Kawamura, I.; Shimomura, K. J. Antibiot. 1994, 47, 315.
10. Bowers, A. A.; West, N.; Taunton, J.; Schreiber, S. L.; Bradner, J. E.; Williams, R. M. J. Am. Chem. Soc. 2008,130, 11219.
11. (e) Nasveschuk, C. G.; Ungermannova, D.; Liu, X.; Phillips, A. J. Org. Lett. 2008, 10, 3595.
12. (f) Numajiri, Y.; Takahashi, T.; Takagi, M.; Shin-ya, K.; Doi, T. Synlett 2008, 16, 2483.
13. (g) Seiser, T.; Kamena, F.; Cramer, N. Angew. Chem., Int. Ed. 2008, 47, 6483.
14. (h) Ying, Y.; Liu, Y.; Byeon, S. R.; Kim, H.; Luesch, H.; Hong, J. Org. Lett. 2008, 10, 4021.
15. Bowers, A. A.; Greshock, T. J.; West, N.; Estiu, G.; Schreiber, S. L.; Wiest, O.; Williams, R. M.; Bradner, J. E. J. Am. Chem. Soc. 2009, 131, 2900.
16. (j) Montero, A.; Beierle, J. M.; Olsen, C. A.; Ghadiri, M. R. J. Am. Chem. Soc. 2009, 131, 3033.
17. (k) Greshock, T. J.; Johns, D. M.; Noguchi, Y.; Williams, R. M. Org. Lett. 2008, 10, 613.
18. Furumai, R.; Matsuyama, A.; Kobashi, N.; Lee, K.-H.; Nishiyama, M.; Nakajima, H.; Tanaka, A.; Komatsu, Y.; Nishino, N.; Yoshida, M.; Horinouchi, S. Cancer Res. 2002, 62, 4916.
19. (a) Doi, T.; Iijima, Y.; Shin-Ya, K.; Ganesan, A.; Takahashi, T. Tetrahedron Lett. 2006, 47, 1177.
20. (b) Takizawa, T.; Watanabe, K.; Narita, K.; Kudo, K.; Oguchi, T.; Abe, H.; Katoh, T. Heterocycles 2008, 76, 275.
21. (a) Li, K. W.; Wu, J.; Xing, W. N.; Simon, J. A. J. Am. Chem. Soc. 1996,118, 7237.
22. (b) Wen, S.; Packham, G.; Ganesan, A. J. Org. Chem. 2008, 73, 9353.
23. Di Maro, S.; Pong, R.-C.; Hsieh, J.-T.; Ahn, J.-M. J. Med. Chem. 2008, 51, 6639.
24. (a) Dawson, P. E.; Muir, T. W.; Clark-Lewis, I.; Kent, S. B. H. Science 1994, 266, 776.
25. (b) Tam, J. P.; Lu, Y. A.; Liu, C. F.; Shao, J. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 12485.
26. (a) Tam, J. P.; Lu, Y. A. Tetrahedron Lett. 1997, 38, 5599.
27. (b) Zhang, L. S.; Tam, J. P. J. Am. Chem. Soc. 1997, 119, 2363.
28. Camarero, J. A.; Muir, T. W. Chem. Commun. 1997, 1369.
29. Camarero, J. A.; Cotton, G. J.; Adeva, A.; Muir, T. W. J. Pept. Res. 1998, 51, 303.
30. Chen, J.; Warren, J. D.; Wu, B.; Chen, G.; Wan, Q.; Danishefsky, S. J. Tetrahedron Lett. 2006, 47, 1969.
31. (a) Botti, P.; Villain, M.; Manganiello, S.; Gaertner, H. Org. Lett. 2004, 6, 4861.
32. (b) George, E. A.; Novick, R. P.; Muir, T. W. J. Am. Chem. Soc. 2008, 130, 4914.
33. Liang, B.; Richard, D. J.; Portonovo, P. S.; Joullie, M. M. J. Am. Chem. Soc. 2001, 123, 4469.
34. Although alkyl /3-mercaptoalcohol linkers with all of the appropriate functionality can be designed without a stereocenter, these would generally require a tertiary thiol or alcohol, which would confer unwanted reactivity or steric hindrance. Disulfide-protected aryl /3-mercaptoalcohols (o-mer- captophenols) are not suitable as Fmoc solid-phase linkers because their esters are cleaved by the secondary amines used for Fmoc deprotection.
35. Evans, C. A.; Bernier, L.; Dugas, J.; Mansour, T. S. Tetrahedron Lett. 1997, 38, 7657.
36. Du, Y.; Chen, Q.; Linhardt, R. J. J. Org. Chem. 2006, 71, 8446.
37. Schnolzer, M.; Alewood, P.; Jones, A.; Alewood, D.; Kent, S. B. H. Int. J. Pent. Prot. Res. 1992, 40, 180.
38. During TLC, the color change and rate of oxidation (little heat required) with ceric ammonium molybdate stain were consistent with the presence of free thiol, and ninhydrin stain indicated a free amine.